Carregant...
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
BACKGROUND: We sought to develop and validate clinically relevant, early assessment continuous tumor measurement–based metrics for predicting overall survival (OS) using the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 data warehouse. METHODS: Data from 13 trials representing 2096 patie...
Guardat en:
| Publicat a: | J Natl Cancer Inst |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4643633/ https://ncbi.nlm.nih.gov/pubmed/26296640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv239 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|